Eric D. Eisenmann

机构：The Ohio State University · ORCID：0000-0003-1176-675X

发表论文 140 篇 · 总被引 580 次 · h-index 14

代表论文

Revumenib in combination with intensive induction and consolidation for newly diagnosed patients with NPM1-mutated or KMT2A-rearranged Acute Myeloid Leukemia: Preliminary results from the Phase 1b etctn 10596 study (2025 · Blood · 被引 2)
Elucidating the Role of S100A9 in Paclitaxel-Induced Peripheral Neuropathy (Abstract ID: 274573) (2026 · Journal of Pharmacology and Experimental Therapeutics)
Development of a Translationally Relevant Strategy to Protect Against Paclitaxel-Induced Peripheral Neuropathy (Abstract ID: 274568) (2026 · Journal of Pharmacology and Experimental Therapeutics)
Ribociclib is not a substrate or inhibitor of Oatp1b-mediated uptake in vivo (2026 · Cancer Chemotherapy and Pharmacology)
Data from: Ribociclib is not a substrate or inhibitor of Oatp1b-mediated uptake in vivo (2026 · DRYAD)
Supplementary Figure 5 from Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine Bioavailability (2026)